| Ident. | Authors (with country if any) | Title |
|---|
| 001F72 (2010) |
Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database |
| 002348 (2009) |
Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Shigeyuki Kojima [Japon] ; Satsuki Mitsuma [Japon] ; Yukari Sekiguchi [Japon] ; Toshihide Kanesaka [Japon] ; Satoshi Kuwabara [Japon] | Dopamine agonist‐induced antecollis in Parkinson's disease |
| 002418 (2009) |
Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Yiong-Huak Chan [Singapour] ; Nigel C. K. Tan [Singapour] | Bromocriptine use and the risk of valvular heart disease |
| 002568 (2008) |
Masaaki Hirayama [Japon] ; Tomohiko Nakamura [Japon] ; Norio Hori [Japon] ; Yasuo Koike [Japon] ; Gen Sobue [Japon] | The video images of sleep attacks in Parkinson's disease |
| 002D48 (2007) |
Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne] | Meta‐analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists |
| 002D98 (2007) |
Claudio Lucetti [Italie] ; Paulo Del Dotto [Italie] ; Gianna Gambaccini [Italie] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Caterina Berti [Italie] ; Giuseppe Rossi [Italie] ; Maria Cristina Bianchi [Italie] ; Michela Tosetti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie] | Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study |
| 003125 (2006) |
Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Seung Woo Park [Corée du Sud] ; Won Yong Lee [Corée du Sud] | Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists |
| 003278 (2006) |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 003D47 (2004) |
Pinky Agarwal [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis] | Diagnosis and management of pergolide‐induced fibrosis |
| 003E39 (2004) |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Trial of subtherapeutic pergolide in de novo Parkinson's disease |
| 003F70 (2003) |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double‐blind, 3‐month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 004114 (2003) |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double‐blind, single‐dose, cross‐over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease |
| 004631 (2002) |
| DA agonists: Ergot derivatives: Pergolide |
| 004707 (2001) |
William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie] | Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations |
| 004B08 (2000) |
Jaime Kulisevsky [Espagne] ; Carmen García-Sánchez [Espagne] ; Marcelo L. Berthier [Espagne] ; Manel Barbanoj [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Armando Estévez-González [Espagne] | Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients |
| 004C27 (1999) |
J. Eric Ahlskog [États-Unis] ; Ryan J. Uitti [États-Unis] ; Michael K. O'Connor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Joseph Y. Matsumoto [États-Unis] ; Kathy F. Stark [États-Unis] ; Margaret F. Turk [États-Unis] ; Omer L. Burnett [États-Unis] | The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease |
| 004E78 (1998) |
Juliane Winkelmann [Allemagne] ; Thomas C. Wetter [Allemagne] ; Karen Stiasny [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Claudia Trenkwalder [Allemagne] | Treatment of restless leg syndrome with pergolide—an open clinical trial |
| 005362 (1997) |
Joseph F. Lipinski [États-Unis] ; Sallee [États-Unis] ; Cherry Jackson [États-Unis] ; Gopalan Sethuraman [États-Unis] | Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide |
| 005A47 (1995) |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 005C60 (1994) |
G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli | Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study |
| 005C96 (1994) |
C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. Yahr | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease |
